Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb)-Reference-Cited by-同舟云学术

Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb)

Published:2011-12-20 Issue:1 Volume:23 Page:89-98
ISSN:0957-4530
Container-title:Journal of Materials Science: Materials in Medicine
language:en
Short-container-title:J Mater Sci: Mater Med

Author:

Lawlor C.,O’Sullivan M. P.,Rice B.,Dillon P.,Gallagher P. J.,O’Leary S.,Shoyele S.,Keane J.,Cryan S.-A.

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Biomaterials,Bioengineering,Biophysics

Link

http://link.springer.com/content/pdf/10.1007/s10856-011-4511-4.pdf

Reference31 articles.

1. Muttil P, Wang C, Hickey A. Inhaled drug delivery for tuberculosis therapy. Pharm Res. 2009;26(11):2401–16.

2. Misra A, et al. Inhaled drug therapy for treatment of tuberculosis. Tuberculosis. 2011;91(1):71–81.

3. O’ Hara P, Hickey A. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterisation. Pharm Res. 2000;17(18):956–61.

4. Sung J, et al. Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm Res. 2009;26(8):1847–55.

5. Pandey R, et al. Poly(dl-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother. 2003;52(6):981–6.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-based particle engineering via spray-drying for targeted delivery of antibiotics to the lung;International Journal of Pharmaceutics;2023-07

2. Application of PLGA as a Biodegradable and Biocompatible Polymer for Pulmonary Delivery of Drugs;AAPS PharmSciTech;2023-01-18

3. A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation;Drug Delivery and Translational Research;2022-09-21

4. Dry powder inhalers of antitubercular drugs;Tuberculosis;2022-07

5. Recombinant ArgF PLGA nanoparticles enhances BCG induced immune responses against Mycobacterium bovis infection;Biomedicine & Pharmacotherapy;2021-05